What Patients Need To Know About Estrogen Patch Shortages
Forbes Talks · Forbes Media LLC
Audio is streamed directly from the publisher (traffic.megaphone.fm) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
In late 2025 and early 2026, the FDA removed the “black box” warning label found on certain menopausal hormone therapy products, including estrogen patches. The removal of this warning paired with a surge in demand for medications for perimenopause and menopause has resulted in a shortage of estrogen patches, leaving many patients scrambling. Dr. Nesreen Hermes, a family medicine doctor in Illinois who regularly sees patients for perimenopause and menopausal symptoms, joined ForbesWomen editor Maggie McGrath to discuss.
Learn more about your ad choices. Visit megaphone.fm/adchoices